The newly formed investment platform, part of biotech REIT Alexandria Real Estate Equities, will invest at life sciences startups at seed stage.
Alexandria Venture Investments, the strategic investment division of life sciences real estate investment trust (REIT) Alexandria Real Estate Equities, has launched a seed-stage investment platform.
The vehicle, Alexandria Seed Capital Platform, is intended to accelerate seed funding for life sciences technology developers by bringing together participants from across the healthcare venture capital space.
Executives from pharmaceutical companies Pfizer, Roche and Eli Lilly will be on the unit’s advisory board together with those from VC firm Arch Venture Partners and life…